Literature DB >> 23672908

Guided growth for the treatment of moderate leg-length discrepancy.

Albert Martin Pendleton1, Peter Morris Stevens, Man Hung.   

Abstract

The purpose of this study was to evaluate the effectiveness and complication rate of guided growth for the treatment of patients with a moderate leg-length discrepancy. The authors retrospectively reviewed all patients treated with guided growth for a moderate leg-length discrepancy at their institution between October 2004 and December 2010. Thirty-four patients met the inclusion criteria from an initial cohort of 105 patients. All patients were followed until screw removal or maturity occurred. Nine patients had a developmental leg-length discrepancy, and 25 had a congenital leg-length discrepancy. Average age was 12.6 years (range, 7-16 years). Average leg-length discrepancies, as measured on standing long-leg radiographs from the top of the pelvis, the top of the femoral heads, and the center of the ankle to the top of the femoral heads, were 22, 19, and 17 mm, respectively. Average discrepancies at screw removal or maturity were 13, 10, and 11 mm, respectively. Twenty of 33 patients had a leg-length discrepancy of less than 1 cm at maturity or screw removal. The leg-length discrepancy change in patients who underwent guided growth of the tibia was minimal. Leg-length discrepancies in patients who underwent guided growth of the femur or both the femur and the tibia changed by an average of 10 mm. One patient had a mechanical axis change greater than 1 zone, and 1 patient required treatment for angular deformity after being treated for a leg-length discrepancy. Guided growth is a safe and effective technique for treating moderate leg-length discrepancies. Copyright 2013, SLACK Incorporated.

Entities:  

Mesh:

Year:  2013        PMID: 23672908     DOI: 10.3928/01477447-20130426-18

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  9 in total

1.  [Special topics in pediatric orthopedics: options and limits of growth guidance].

Authors:  B Vogt; M Horter; R Rödl
Journal:  Orthopade       Date:  2014-08       Impact factor: 1.087

2.  Tension-band Plating for Leg-length Discrepancy Correction.

Authors:  Jaap J Tolk; Rajiv Merchant; Peter R Calder; Aresh Hashemi-Nejad; Deborah M Eastwood
Journal:  Strategies Trauma Limb Reconstr       Date:  2022 Jan-Apr

3.  Growth Deceleration for Limb Length Discrepancy: Tension Band Plates Followed to Maturity.

Authors:  Peter Stevens; Matias Desperes; Philip K McClure; Angela Presson; Jennifer Herrick
Journal:  Strategies Trauma Limb Reconstr       Date:  2022 Jan-Apr

Review 4.  [Guided growth in children and adolescents. Correction of leg length discrepancies and leg axis deformities].

Authors:  B Vogt; F Schiedel; R Rödl
Journal:  Orthopade       Date:  2014-03       Impact factor: 1.087

Review 5.  The Actions of IGF-1 in the Growth Plate and Its Role in Postnatal Bone Elongation.

Authors:  Holly L Racine; Maria A Serrat
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

6.  Rotational deformities of the long bones can be corrected with rotationally guided growth during the growth phase.

Authors:  Mutlu Cobanoglu; Emre Cullu; Figen Sevil Kilimci; Mehmet Kamil Ocal; Rahime Yaygingul
Journal:  Acta Orthop       Date:  2016-02-22       Impact factor: 3.717

Review 7.  The role of guided growth as it relates to limb lengthening.

Authors:  Peter M Stevens
Journal:  J Child Orthop       Date:  2016-12-02       Impact factor: 1.548

8.  Design of a New "U"-shaped Staple and Its Clinical Application in Postoperative Ankle Valgus of Congenital Pseudarthrosis of the Tibia in Children.

Authors:  Xiongke Hu; Anping Li; Kun Liu; Jiangyan Wu; Haibo Mei
Journal:  Orthop Surg       Date:  2022-07-20       Impact factor: 2.279

9.  Tension band plates have greater risks of complications in temporary epiphysiodesis.

Authors:  You-Hung Cheng; Wei-Chun Lee; Yi-Feng Tsai; Hsuan-Kai Kao; Wen-E Yang; Chia-Hsieh Chang
Journal:  J Child Orthop       Date:  2021-04-19       Impact factor: 1.548

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.